TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Tarlatamab for People With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
- Status
- RECRUITING
- Phase
- PHASE1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients
- Status
- COMPLETED
- Phase
- N/A
Olpasiran Expanded Access Program
- Status
- AVAILABLE
- Phase
- N/A
Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
- Status
- RECRUITING
- Phase
- PHASE1
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Status
- RECRUITING
- Phase
- PHASE3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Status
- RECRUITING
- Phase
- PHASE3
Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
- Status
- RECRUITING
- Phase
- PHASE2
TIDHI Mental Health in IBD Patients Study
- Status
- RECRUITING
- Phase
- NA